glp-1 wiki What is and Its Receptor Agonists? PDB-101: Diabetes Mellitus: Diabetes Mellitus:

For example, rat TDSCs treated with IGF-1 (1, 10, and 100 ng/mL) for 28 days exhibited the increased expression of tendon-specific marker (SCX) and significantly decreased expression of chondrogenic and osteogenic marker (collagen type II) ( in vitro culture with significant upregulation of tenocytic markers (SCX, collagen type III, and decorin) ( in vivo data are available regarding the efficacy of exogenously delivery of IGF-1 in combination with stem cells to treat tendon injury

Metabolic fate of polyphenols in the human superorganism. Proc

[7] As a result, MB is contraindicated in patients with known G6PD deficiency, and screening for this enzyme deficiency is recommended when considering MB therapy, especially in populations where G6PD deficiency is more prevalent

nonetheless, significant factors must be considered for patient selection and monitoring

J Clin Endocrinol Metab (2007) 92:376473